Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Understanding the development of a potential flu vaccine utilizing mRNA technology to protect against many subtypes of the Influenza Virus

Ticker(s): IBB

Who's the expert?

Infectious disease expert and departmrent chair at the University of Alabama Birmingham
Flu Vaccine Expert, research has been cited over 11,000 times

Interview Goal

To better understand the development of a new mRNA flu vaccine to create near universal protection against influenza accompanied by a review of a recent publication on this topic.

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.